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nessed death. Autopsy results are not available. The rest of the patients died for non-car- 
diac causes. In conclusion, alcohol septal ablation is effective in reducing the left 
ventricular outflow tract gradient, decreasing the asymmetric septal hypertrophy with sig- 
nificant relief of symptoms. The intermediate-tarm overall mortality rate was 4%. Patients 
with small septal arteries may not be adequate candidates for this therapy. Redo proce- 
dures are effective in patients with incomplete benefits after initial treatment. 
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845-2 Long-Term Outcome After Percutaneous Septal  
Ablation for Hypertrophic Obstructive Cardiomyopathy 
Dirk Weloe. Lothar Faber, Bemd C. Werlemann, Leon Krater, Hubert Seggewiss, Ulrich 
Gleichmann, Dieter Horstkotta, Heart Center North Rhine-Westphalia, Bad Oeynhausen, 
Germany, Leopoldina Hospital, Schweinfurt, Germany, 
Introduction: Septal ablation (PTSMA) improves outflow gredients (LVOTG) and symp- 
toms in symptomatic patients (pts.) with hypertrophic obstructive cardiomyopathy 
(HOCM). We analyzed the long-term outcome (41±11 [24-67] months) of the first 178 
consecutive pts. treated between 1/1996 and 12/t998. 
Results: 3 pts. died during in-hospital stay (VF, pulmonary embolism, and pericardial 
tamponade in 1 pt. each). Mean CK rise was 599±300 U/I. A DDD-pacemaker (DDD-PM) 
had to be implanted in 13 pts. (7%), 11 pts. (6%) underwent re-PTSMA and 3 pts (2%) 
myectomy. 4 pts. were lost to follow-up. There were 2 further DDD-PM implantations and 
2 ICD implantations (after out-of-hospdal CPR for unknown reasons in a 23 year-old 
woman, and after sustained VT in a 74 year-old man with coexistent coronary artery dis- 
ease). 6 pts. died during follow-up: due to stroke (86 years), coexistent obstructive pul- 
monary disease (76 years), colon cancer (79 years), after unsuccessful out-of-hospital 
CPR (25 years), and due to unknown causes (76 and 54 years, resp.). Additional data 
are shown in the table. 
Conclusions: PTSMA leads to LVOTG reduction and improvement of exercise capacity 
which persist during long-term follow up, Degeneration of the AV conduction system 
together with the PTSMA-induced damage may require a DDD-PM implantation in some 
patients. A total mortality rate of 9/178 (5%) including all procedure-rolatad deaths com- 
pares favorably with the reported natural course of this pt. group with advanced disease. 
Baseline Last follow-up p-value 
NYHA class 2.8±0.6 1.6±0.7 <0.0001 
LA diameter (MM) 48±8 45±8 <0.01 
LVOTG at rest (mmHg) 60±35 7±14 <0.0001 
LVOTG at Valsalva (mmHg) 127±50 20±28 <0.0001 
Maximum workload (watts) 87±53 121:L-42 <0.0001 
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845-3 Pred ic t ion  of  the  Risk of  Pacemaker Dependency After 
Percutaneous Septal Ablation for Hypertrophic 
Obstructive Cardiomyopsthy 
l..othar Faber. Hubert Seggewiss, Bernd C. Wedemann, Dieter Fassbender, Henning K. 
Schmidt, Dieter Horstkotte, Heart Center North Rhine-Westphalia, Bad Oeynhausen, 
Germany, Leopoldina Hospital, Schweinfurt, Germany. 
Background and introduction: Damage of the AV conduction system is a major complica- 
tion of percutaneous septal ablation (PTSMA) which requires early and reliable identifica- 
tion of patients (pts.) at risk for complete heart block (CHB). 
Methods and results: In the first 33 pts. who underwent PTSMA in our institution, AV con- 
duction recovery occurred after 11 days in one pt.; another pt. suffered from unexpected 
CHB after 9 days. 7 pts. who received a DDD pacemaker (PM) were compared to those 
without conduction disturbances. A score was calculated to identify all PM candidates 
retrospectively with >12 points. In the following 256 consecutive pts., this score was 
applied prospectively. 13 of 14 pts. (93%) who needed a PM were correctly identified by 
this scoring system, while 1 pt. with a score of 13 had conduction recovery after short- 
term steroid therapy. All pts. with 8 points; p<0.01). 
Conclusions: Based on monitodng for the first 48 hours following PTSMA, identification 
of pts. at risk for CHB is feasible. Pts. with a score <8 can be considered to be at low, 
those with >12 points at high risk. In all other cases watchful waiting with prolonged mon- 
itoring may allow AV conduction to recover, thus reducing the number of unnecessary 
PM implantations. 
Cutoff value Score points 
Baseline PQ interval (ms) > 160 + 2 
Baseline minimal HR (Holter, bpm) < 50 + 2 
Baseline gradient (Echo, mm Hg) > 70 + 2 
CHB during PTSMA at any time yes + 2 
CHB on arrival at coronapJ care unit yes + 2 
AV conduction recovery after 12 hs yes - 2 
No AV conduction after 12 hs yes + 1 
No AV conduction after 24 hs yes + 2 
No AV conduction after 48 hs yes + 3 
QRS duration after 48 hs (ms) > 155 + 3 
"riming of the GOT peak (hs) > 16 ÷ 1 
>20 +3 
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845-4 Echocard iogrems of  Ext remely  Heavy Weight Athletes 
Mimicking Dilated Cardiomyopethy 
Nodmitsu Kinoshita. Satoshi Yamamoto, Fuminod Katsukawa, Shohei Onishi, Hajime 
Yamazaki, Sports Medicine Research Center, Keio University, Yokohama, Japan, Health 
Science Center, Kansai Medical University, Osaka, Japan. 
Background: Since cardiomyopathy is important etiology for sudden death of young ath- 
letes, the upper limit of cardiac dimensions increased with training and gaining body 
weight in athletes is a key issue for the differential diagnosis of athlete's heart. This study 
was aimed to reveal one extreme of cardiac dimensions in the athletic population of 
extremely heavy weight. 
Methods: Records of both cardiac and body dimensions of 348 Japanese male profes- 
sional sumo wrestlers (mean age, 21.8 years; range, 15-39 years) were chosen from the 
entire population of Japan Sumo Association. Criteria of the selection were; 1) blood 
pressure <140/90mmHg, 2) plasma brain natriuretic peptide <17.gpg/ml, 3) no abnormal 
Q wave and ST-T change nor left bundle branch block on electrocardiogram, and 4) free 
of cardiovascular disease. Cardiac dimensions and body composition had been deter- 
mined by echocardiography and air displacement plethysmography, respectively. Data 
were shown as mean+SD (range). 
Results: Weight, height, fat percent, and fat free mass were 118+_.21 (62-182) kg, 
179.3+5.5 (185-199) cm, 29.6-+6.4 (9.8-46.4) %, and 82_+10 (52-126) kg, respectively. 
End diastolic dimension (Dd), end systolic dimension (Ds), interventricular septal thick- 
ness (IVS), and posterior wall thickness (PW) of the left ventricle were 58.4+3.8 (46-70) 
ram, 38.9-+3.7 (30-49) ram, 10.2_+0.9 (8-13) ram, and 10.2_+0.9 (7.5-13) mm, respectively. 
E wave to A wave velocity ratio were 0.5_+0.2 (0.2-1.0). Dd were significantly (p<O.01) 
correlated with fat mass (r=0.26) and fat free mass (r=0.31) and exceeded the generally 
regarded upper limit of normal value (54ram) in 84.5% of the subjects. Relative wall thick- 
ness determined as (IVS+PW)/Dd were 0.35_+0.04 (0,25-0.48) and were under the gen- 
erally accepted cut point (0.45) in 99%. 
Conclusion: As athletes gained a large amount of fat and fat free mass concomitantly. 
eccentric left ventdcular hypertrophy with exceedingly beyond the upper limit of the nor- 
mal cavity dimension was commonly observed on their echocardiograms which might 
mimic dilated cardiomyopathy. The diagnosis of dilated cardiomyopathy should not be 
made by solely depending on cardiac morphology in this population. 
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845-5 Significance and Relationship Between Magnitude of  
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Heart Institute Foundation, Minneapolis, Minnesota, Barnes-Jewish Hospital 
Washington University School of Medicine, SL Louis, Missouri. 
Background: Hypertrophic cardiomyopathy (HCM) is associated with both sudden car- 
diac death and disabling symptoms. In HCM there is a direct relationship between left 
ventricular (LV) wall thickness and likelihood of sudden death, with extreme phenotypic 
expressions conferring greatest risk (LV thickness _> 30 mm). However, relation between 
magnitude of LV hypertrophy (LVH) and degree of functional disability, and whether 
severity of the HCM phenotype (and, in particular extreme LVH) determines magnitude of 
symptoms, is unresolved. 
Methods: We analyzed 477 consecutive HCM patients at Minneapolis Heart Institute 
and compared max. LV wall thickness by 2-D echo with level of congestive symptoms 
(exertional dyspnea/chest pain), by New York Heart Association (NYHA) class. 
Results: The relation between congestive symptoms and LVH was parabolic with more 
severe symptoms significantly associated with only moderate LVH (max. wall thickness = 
20-24 ram), but not with either mild (_< 15 ram) or extreme LVH (_> 30 mm) - - (p < 0.001; 
see table). 
Conclusion: Congestive symptoms and functional limitation in HCM were less com- 
monly associated with either massive or particularly mitd LVH than with moderate 
degrees of LV wall thickening (i.e., 20-24 ram; average for HCM). Therefore, while 
extreme phenotypic expression of HCM is linked to risk for sudden death, it is not a 
determinant of congestive symptoms. Within the HCM disease spectrum, magnitude of 
LVH relates much differently to functional disability than to sudden death. 
FUNCTIONAL CLASS (NYHA) 
Max. LV wall Mean Class I Class Ill/IV 
Thickness(mm) (no symptoms) (severe symptoms) 
-< 15 1.47 27/43 (63%) 3/43 (7%) 
16-19 1.89 60/151 (40%) 32/151 (21%) 
20-24 1.96 50/164 (30%) 47/164 (29%) 
25-29 1.86 25/63 (40%) 15/63 (24%) 
-> 30 1.66 28/56 (50%) 9/56 (16%) 
